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Abstract
Background: Noncommunicable diseases (NCDs), including mental health, have become a major concern in low-
and middle-income countries. Despite increased attention to them over the past decade, progress toward
addressing NCDs has been slow. A lack of bold policy commitments has been suggested as one of the contributors
to limited progress in NCD prevention and management. However, the policies of key global actors (bilateral,
multilateral, and not-for-profit organisations) have been understudied.
Methods: This study aimed to map the key global actors investing in action regarding NCDs and review their
policies to examine the articulation of priorities regarding NCDs. Narrative synthesis of 70 documents and 31 policy
papers was completed, and related to data collated from the Global Health Data Visualisation Tool.
Results: In 2019 41% of development assistance for health committed to NCDs came from private philanthropies,
while that for other global health priorities from this source was just 20%. Through a range of channels, bilateral
donors were the other major source of NCD funding (contributing 41% of NCD funding). The UK and the US were
the largest bilateral investors in NCDs, each contributing 8%. However, NCDs are still under-prioritised within
bilateral portfolios – receiving just 0.48% of US funding and 1.66% of the UK. NGOs were the key channels of
funding for NCDs, spending 48% of the funds from donors in 2019. The reviewed literature generally focused on
NCD policies of WHO, with policies of multilateral and bilateral donors given limited attention. The analysis of
policies indicated a limited prioritisation of NCDs in policy documents. NCDs are framed in the policies as a barrier
to economic growth, poverty reduction, and health system sustainability. Bilateral donors prioritise prevention, while
multilateral actors offer policy options for NCD prevention and care. Even where stated as a priority, however,
funding allocations are not aligned.
Conclusion: The growing threat of NCDs and their drivers are increasingly recognised. However, global actors’
policy priorities and funding allocations need to align better to address these NCD threats. Given the level of their
investment and engagement, more research is needed into the role of private philanthropies and NGOs in this
area.
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Introduction
Noncommunicable diseases (NCDs) – namely cardiovas-
cular diseases, cancer, chronic respiratory diseases, and
diabetes – have become a major concern in low- and
middle-income countries (LMICs) due to their rising
prevalence contributing to premature mortality [1]. In
2016, 71% of 56.9 million global deaths were caused by
NCDs. Three-quarters of NCD deaths (31.5 million) oc-
curred in LMICs. Almost half of these deaths (46%) oc-
curred before the age of 70 [2, 3]. Further, more than
80% of people experiencing mental disorders and sub-
stance abuse live in LMICs [4]. The increasing burden of
NCDs, including mental health in LMICs, is putting
strains on their struggling health systems as well as so-
cial and economic development [2, 5, 6].
In the past decade, NCDs have risen up the global
agenda. High-level meetings of the UN General Assem-
bly on NCDs were held in 2011, 2014, and 2018 [1]. As
a result, important policy documents were developed: a
Global Action Plan for the Prevention and Control of
NCDs for 2013–2020 and an NCD Global Monitoring
Framework (2013) [2]. NCDs were also included in the
Sustainable Development Goals (SDGs). Goal 3.4 states:
“by 2030 reduce by one-third premature mortality from
noncommunicable diseases through prevention and
treatment and promote mental health and well-being”
[3]. The share of development assistance for NCDs has
been slowly growing in the last decade (e.g. from 1.2% in
2010 to 1.7% in 2016) [5, 7].
However, a recent review of the progress towards SDG
3.4 showed that it was inadequate in most countries [3].
This issue is particularly acute in low-income and fragile
settings. Hence, the review recommended that the inter-
national community increase financing and lending for
the prevention and management of NCDs through bilat-
eral and multilateral channels and through multi-donor
funds and other innovative financing mechanisms [3].
For the most part, donors have been reluctant to make
significant investments in NCDs, including mental
health because (a) NCDs are not considered to be an im-
mediate risk to others, and responsibilities lie with the
individual behaviour [7, 8], (b) there is a dearth of data
on the cost-effectiveness of interventions to address
NCDs [7, 9–12], and (c) communicable diseases have
established, low-cost strategies for management within
the health sector which are easier to deliver than com-
plex behaviour change strategies and a whole of society
approach for NCD prevention and control which are
multisectoral [7, 11].
Recently, Shilton [13] suggested that a lack of commit-
ment to bold policies was an important reason for weak
investment in NCDs. This point is of particular rele-
vance given that donors play an important role in polit-
ical guidance that influences agenda-setting and
interventions at the national level [14, 15]. Examining
their policies and funding can shed light on their com-
mitments to NCDs.
This study examined the involvement of global actors
(bilateral, multilateral, and not-for-profit organisations)
in investment regarding NCDs in LMICs since 2010 by
mapping the key actors and reviewing their policy docu-
ments and relevant literature to understand their com-
mitment to NCD prevention and management. In
particular, the study addressed three research questions:
(a) who are the key actors and institutions investing in
NCDs, and through which channels do they provide
funding? and (b) to what extent are priorities regarding
NCDs clearly articulated in the policies of donors and
(c) how far do stated policy priorities and funding match
one another?
Methods
The study deployed a comprehensive literature search
since 2010, a review of current policy documents from
key global actors, and an analysis of the funding database
for 2019.
Literature review
A systematic search to identify relevant literature was
undertaken in November–December 2019. The
Cochrane Library, PubMed, Web of Science, PsychInfo,
Scopus, and CINAHL were searched for published stud-
ies. Searches included terms to capture noncommunic-
able diseases (e.g. ‘noncommunicable disease’, ‘chronic
disease’ and specific disease terms), global actors (e.g.
‘bilateral’, ‘multilateral’, ‘donors’), funding and policy
terms (e.g. ‘funding’, ‘development assistance’, ‘policy’),
and low- and middle-income countries. The full search
strategy can be found in Additional file 1.
Studies were screened based on the eligibility criteria
outlined in Table 1. Studies were included if they were
published since 2010. The study focused on the last dec-
ade because NCDs had received increased attention in
this period resulting in a number of UN high-level meet-
ings, adoption of such key policy documents as the
WHO Global Action for NCD prevention and Control
2013–2020, and importantly inclusion of NCDs into the
SDGs.
Screening was undertaken by three researchers. Due to
time constraints, results were single screened, however,
frequent discussions were undertaken between re-
searchers regarding inclusion and exclusion to ensure a
shared understanding and consistent application of in-
clusion criteria. Additionally, one researcher reviewed all
included studies to ensure inclusion criteria had been
met.
Data extraction was undertaken by two researchers.
The extraction form was designed in Excel and included
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information on: general identifiers, such as authors and
year; study descriptors, such as setting, study purpose,
and study focus; methodology, such as study design,
population, and data source; relevant findings around
funding and policy priorities; recommendations made by
authors; and limitations identified. The extraction sheet
was designed a priori and modified as required following
piloting. The data extraction template can be found in
Additional file 1.
Funding Database
The Financing Global Health Data Visualisation Tool by
the Institute of Health Metric and Evaluation (University
of Washington) was used to obtain data on NCD and
non-NCD funding sources and channels for 2019 to
identify key funders of NCD action and the main actors
in channelling NCD funds. This tool was selected from a
number of tools explored (see Additional file 1) on the
basis of comprehensiveness.
Policy review
Based on the preliminary analysis of Financing Global
Health Data, five key groupings of global actors were se-
lected for the analysis of their policy documents: 1) UN
agencies (namely WHO, UNDP, UNICEF, UNFPA), 2)
Development Banks (i.e., World Bank (WB), Asian De-
velopment Bank (ADB), Inter-American Development
Bank (IADB), African Development Bank (AFDB)), 3)
European Commission, 4) Bilateral development
partners and 5) the Bill and Melinda Gates Foundation
and other philanthropies and foundations. Policy docu-
ments included policies, strategies, and policy briefs in
relation to NCDs and health in general. If no NCD or
health-related policies were found, foreign or develop-
ment aid documents were included in the analysis. Pol-
icy documents were searched on the websites of these
actors as well as in the Google search engine. The search
terms included ‘noncommunicable’, ‘noncommunicable’,
‘health’, ‘human capital’, ‘foreign aid’, ‘development aid’,
‘strategy’, ‘policy’, and ‘policy brief’.
Data extraction of policy documents was undertaken
by one researcher, using an additional data extraction
template. Information was extracted on: the name of the
actor; the title of the policy document; references to
NCDs; and other health priorities indicated. The policy
extraction template is available in Additional file 1.
Analysis
Analysis across the included studies and policies of five
global actor groups identified key themes around fund-
ing and policies in relation to NCDs and brought them
together in a narrative synthesis. Research questions
served as a key framework for the analysis. Data to
examine the first research question (Who are the key ac-
tors and institutions in NCDs and through which chan-
nels do they provide funding?) was drawn from the
Financing Global Health Database and studies identified
through the literature search. The second research
Table 1 Criteria for selecting studies
Domain Criteria
Time restriction Study published since 2010
Language
restriction
Study published in English
Population Bilateral, multilateral, and international development organisations, international non-governmental organisations, international
non-for-profit organisations including philanthropy of businesses and corporations
Topical focus NCD funding, policies, and priorities
Study type Qualitative and quantitative studies
Table 2 Most frequently referenced actors in the reviewed literature according to type
Category Actor Mentions
Multilateral WHO and WHO regional bodies 45





Philanthropies and foundations Bill and Melinda Gates Foundation 7
Bloomberg Philanthropies 5
Wellcome Trust 2
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question (To what extent are priorities regarding NCDs
clearly articulated in the policies of donors?) was an-
swered through an analysis of policy documents and
studies identified through the literature review. In the
case of the policy document review, the analysis was
done qualitatively by interpreting the meaning of the
relevant text [16]. The third question was answered by
comparing results across the first and second questions.
Results
In addition to data obtained from the Financing Global
Health Data Visualisation Tool, the literature search
identified 70 studies. The majority of these studies were
primarily general or global papers (n = 45); 12 studies
had a regional focus (including Latin America and the
Caribbean, the Gulf Region, sub- Saharan Africa, North
Africa, and the Middle East, the Eastern Mediterranean,
and East and South Asia); and 13 studies focused on one
or more specific countries. These 13 studies included 37
different countries, the most frequent being India (in 10
studies), South Africa (7 studies), Uganda (6 studies),
and Nigeria (5 studies). The majority of papers discussed
NCDs – both physical and mental – as one group; how-
ever, 15 papers focused mostly on mental health, and
nine mostly on physical aspects of NCDs. The search of
key actors’ policies identified 31 policy documents. The
majority of actors referenced in relation to NCDs were
multilateral donors or actors (referenced in 76% of pa-
pers), followed by philanthropies and foundations (in
33% of papers), and bilateral donors or actors (in 27% of
papers). Table 2 shows the number of mentions of
NCDs for the three most frequently referenced actors
within each of these categories. Private for-profit actors
and public-private partnerships were mentioned in only
five papers.
Policy documents included policies, strategies, and
policy briefs in relation to NCDs and health in general.
On average, two policy documents from each institution
(n = 16) within the five actor groupings were included.
Policy related documents from philanthropies were lack-
ing. Online information from the website of the Gates
Foundation, as the key foundation investing in health,
including NCDs, was retrieved for the analysis. A full list
of the documents analysed can be found in Additional
file 1.
Mapping of key global actors investing in NCD action
In 2019, a total figure of around $41 billion was spent
on global health through mechanisms of Development
Assistance for Health (DAH). About 1.81% of this ($ 733
million) was spent on NCDs. As Fig. 1 shows, 41% of
DAH committed to NCDs came from private philan-
thropies, while philanthropic funding for other global
health priorities was just 20%. Bilateral donors were the
other major source of NCD funding (contributing 41%
of DAH funds committed). This differs from the funding
sources of other health areas (i.e., non-NCD) where
most funding (68%) came from bilateral donors. Figure 2
shows that the UK and the US are the largest bilateral
investors in NCDs, each contributing 8%. Other key bi-
lateral investors include Germany, France, Canada, and
Australia.
NCD funding is channelled through a range of organi-
sations (see Figs. 3 and 4). NGOs are the key channels of
funding for NCDs, utilising 48% of the funds from do-
nors in 2019. A lower percentage of funds (32%) utilises
NGO channels for non-NCD areas. Multilateral actors
such as development banks and UN agencies are the
second largest channel of funding for NCDs, also playing
a proportionately larger role for NCD than other health
expenditures.
NGOs, as a key channel for NCD interventions, re-
ceive funds from all sources, with private philanthropy
and governments being the main funders. UN agencies,
as the second important channel for NCD interventions,
also receive funds from multiple sources, with bilateral
and multilateral actors being the largest ones. Develop-
ment banks, the third key channel, mostly disburse dir-
ectly to governments (Fig. 5).
Private philanthropy and NGOs are important actors
in NCD funding and action. Prominent philanthropies
involved in NCD and mental health work identified in
the reviewed literature include Bloomberg Foundation,
GE Foundation [11, 14], MasterCard Foundation, Unile-
ver Foundation, and Atlantic Philanthropies [8]. Inter-
national NGOs engaged in NCD and mental health
action include the World Heart Federation, the Inter-
national Union against Cancer, Basic Needs, and Handi-
cap International [12, 17–20].
Review of policy documents
Published literature
The reviewed literature mostly discussed WHO policies
related to NCDs in terms of the policies’ implementation
and effectiveness. Key policies include the WHO Global
Strategy for the Prevention and Control of Noncommu-
nicable Diseases [19], WHO Global NCD Action Plan
2013–2020 [2, 21–26], WHO’s Framework Convention
on Tobacco Control [1, 21, 27–31], WHO Mental
Health Action Plan and Mental Health Gap [22, 32–34],
WHO Strategy to Reduce Harmful Alcohol Consump-
tion [26], WHO Best Buys [35], WHO Package of Essen-
tial NCDs Interventions for Primary Healthcare [35–37].
Bilateral actors
The US, UK, Germany, France, Canada, and Australia
were identified as the main bilateral actors investing in
NCDs, and our bilateral policy review was thus focused
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on documentation from these donors. Table 3 presents
a) an overview of the NCD statements in the key policy
documents identified for each funder, b) contribution of
each donor to NCD funding in 2019, and c) NCD fund-
ing allocation within the health funding portfolio of each
donor (i.e., internal allocation) in 2019.
As shown above, the UK contributed 8% to DAH on
NCDs in 2019. Table 3 indicates that the UK is second
in terms of NCD funding allocation within the health
funding portfolio (1.7%). However, there is no mention
of NCDs among health priorities in the UK Strategy for
International Development as of 2015. Health priorities
include infectious diseases including malaria, diseases of
epidemical potential such as Ebola, neglected tropical
diseases, drug-resistant infections, antimicrobial resist-
ance, and disease outbreaks [38]. The strategy also aims
to continue MDG commitments, namely child immun-
isation, nutrition, child and maternal death, and family
planning. This strategy was developed on the outcomes
of the 2015 Spending Review that assessed how the aid
budget was spent. Only those projects that were identi-
fied to represent good value for money and in line with
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the UK objectives - such as reducing poverty and tack-
ling global challenges that threaten British security and
interests – are included [38]. In this exercise, prior com-
mitment to addressing NCDs in the 2011–2015 policy
appears to have been deemphasised [39].
The US also contributed 8% to DAH on NCDs in
2019. However, the US internally allocated the least
(0.5%) to NCD action within its health funding portfolio
among all actors reviewed (Table 3). The US’s current
global health focus is primarily on child and maternal
health, infectious diseases, and HIV/AIDS [40]. NCDs
are not mentioned in the key policy documents that
shape the foreign policy and international development
agenda of the USA, namely the National Security Strat-
egy (NSS; 2017, 42] and USAID policy framework [41].
In the NSS under the Trump administration, health has
been mostly mentioned in terms of biothreats and pan-
demics (e.g., Ebola and SARS) [42]. The USAID policy
framework indicates health to be important for people’s
productivity to promote development and reach their
country’s self-reliance, which is USAID’s new vision
[41]. However, before Trump’s administration (January
2017 – January 2021), NCDs and global health in gen-
eral were more salient in the US’s policy documents and
political agenda [43]. Obama’s NSS referred to MDGs
and SDGs and had a section on global health security
(Obama’s administration dates – January 2009 – January
2017) [43]. Obama’s strategy laid the basis for the Global
Health Initiative 2012–2016, which recognised NCDs as
an emerging threat and health system strengthening as a
way to tackle the NCDs [44]. Biden has called for
strengthening the focus on health and healthcare [45].
On his first day of presidency, he halted a decision of
the Trump administration to withdraw from WHO [46].
In 2019, Germany’s contribution to DAH on NCDs
was 4%. The proportion of NCD funding within its
health funding portfolio in 2019 was low (1.4%). How-
ever, unlike the UK and US, Germany has a global
health strategy as of 2014, which identifies NCDs as a
Fig. 1 DAH in 2019 broken down by actor grouping for NCDs and
other health areas (child and maternal health, HIV/AIDs, malaria, TB,
and others)
Fig. 2 NCD funding sources in 2019
Fig. 3 Channels of DAH for NCDs compared to channels of DAH to
other health areas (child and maternal health, HIV/AIDs, malaria, TB,
and others) in 2019. The category of NGOs also includes the
Gates Foundation
Fig. 4 NCD funding channels in 2019
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global problem causing avoidable mortality and under-
mining opportunities for development, economic
growth, social and political stability, and poverty reduc-
tion in LMICs. The policy also recognises four factors,
namely malnutrition, lack of exercise, tobacco consump-
tion, and excessive alcohol consumption, as driving
forces of NCDs’ rise. Thus, one of its focuses (Policy
Focus 3) aims to promote a) prevention of NCDs with
an emphasis on tobacco control, combatting harmful al-
cohol consumption, and promoting healthy eating and
physical exercise, b) inter-sectoral cooperation, and c)
strengthening health systems to prevent NCDs [47].
France contributed 2% to DAH on NCDs in 2019,
which represents 1.5% of its health funding portfolio.
Similar to Germany, France has a strategy for global
health adopted in 2017, which recognises NCDs as a
leading cause of mortality in the world and indicates that
the growing burden of NCDs is depleting health systems
[48]. The strategy of France, as the one by Germany,
aims to take a preventive approach (tobacco, alcohol,
nutrition, and physical activity), promote inter-sectoral
cooperation, and strengthen health systems with a focus
on testing, diagnostics, and management. Global strat-
egies of both Germany and France emphasise the role of
WHO in NCD action and express an intention to sup-
port NCD-related initiatives of WHO [47, 48]:
“As part of the continuum of services, from preven-
tion to care, France will implement the following ac-
tions: a) share its experience and help implement
specific action plans (tobacco, alcohol, nutrition and
physical activity) to encourage healthy lifestyles; b)
step up tobacco control efforts, ensure that the WHO
Framework Convention on Tobacco Control is ap-
plied, and fight addiction; c) encourage people to be
more physically active, given that a sedentary life-
style is a threat to global public health, and encour-
age targeted nutrition-focused actions; d) promote
testing, diagnostics and the rapid management of
diseases; e) advocate a graduated and inclusive
service delivery ranging from local to specialist care;
f) involve patients’ associations, economic stake-
holders and healthcare workers in prevention and
care.” [48]
Despite contributing a similar percentage of DAH to
NCDs as France (2%), which represents 1.6% of its
health funding, Canada does not seem to have a policy
on global health, including NCDs. The government web-
site states that Canada’s global health priorities include
diarrhoea, HIV/AIDs, Malaria, Polio, and TB, which are
addressed through working with development partners
to strengthen the health systems to ensure the provision
of critical services, medicine, and interventions [49].
Since 2010, Canada has also focused on mental health
through Grand Challenges Canada [50].
Australia’s contribution to DAH on NCDs in 2019 was
the least (1%) among six donors. However, its internal
allocation to NCD action was the highest (2.5%) among
bilateral donors. The Australian Health for Develop-
ment Strategy 2015–2020 recognises NCDs’ increasing
burden, which weakens health systems that are
already struggling to deal with infectious diseases and
provision of quality maternal, newborn, and child
healthcare. Thus, the strategy focuses on strengthen-
ing health systems and key partners’ capacity to
strengthen chronic disease prevention, surveillance,
and treatment system [51]. Geographically, the strat-
egy focuses on Southeast Asia and the Pacific as
Australia considers this region to be of direct rele-
vance to Australian domestic interests [51].
Multilateral actors
Table 4 provides a) an overview of the NCD statements
in the key policy documents identified for each funder,
b) contribution of each actor grouping (i.e., Banks and
UN agencies) to NCD funding in 2019, and c) NCD
funding allocation within health funding portfolio of
each actor grouping (i.e., Banks and UN agencies) in
2019.
Fig. 5 Sources and channels of NCD funding in 2019. Source: https://vizhub.healthdata.org/fgh/
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11% ($ 80 million) of DAH on NCDs came from de-
velopment banks, and only 3.1% (80 million of 2.6 billion
of DAH from the Banks) was directed to NCD preven-
tion and control activities (Table 4). Policies of most
banks analysed have a reference to NCDs, which were
recognised as a major barrier to economic development
and poverty reduction. The World Bank and Asian De-
velopment Bank (ADB) invest in UHC and Health Sys-
tem strengthening to address NCDs [52–55]:
“A significant increase has occurred in premature
deaths related to chronic diseases (diabetes, pulmon-
ary diseases, hypertension, cancer) linked to the
tobacco-addiction and obesity pandemics. Malnutri-
tion is problematic not only in poor countries (with
both undernutrition and obesity), but also in rich
countries confronted with a rapidly growing preva-
lence of obesity. … .. An increasing burden of NCDs
in developing countries will put an enormous strain
on their weak health systems. Sound health policies
are essential, for example, to protect households from
the impoverishing effects of catastrophic costs associ-
ated with NCD-related medical care. However, in
countries with weak health systems, reaching the
people needing these interventions through health
service delivery mechanisms and improved basic nu-
trition is challenging. Strengthening health system-
s—so that these services can be delivered effectively,
sustainably, and when needed—is critical to ensure
that investments in health continue to foster eco-
nomic growth to overcome poverty in generations to
come” [53].
The Inter-American Development Bank (IADB) has a
policy with the most elaborate focus on tackling NCDs
by raising awareness about healthy lifestyles, promoting
access to high-quality health services and nutrition, and
promoting financial protection and efficient leadership
and governance in the health sector [56]. The strategy of
the African Development Bank (AFDB) does not have a
reference to NCDs [57].
UN agencies contributed 6.7% of DAH on NCDs in
2019. Within their health funding portfolio, 3.5% were
allocated for NCD prevention and control, which makes
UN agencies a group with the greatest internal priori-
tisation of NCDs. WHO is the key actor at the inter-
national level, with a leadership and coordination role in
promoting and monitoring global action against the ris-
ing burden of NCDs. The WHO Global Strategy for the
Prevention and Control of Noncommunicable Diseases,
Global NCD action Plan 2013–2020, and Mental Health
Action Plan 2013–2020 provide member states and
international partners with a road map and menu of pol-
icy options (i.e., best-buys) to implement various
measures such as increasing tobacco taxes, reducing salt
in food, and promoting access to affordable medicine:
“The Global Action Plan provides Member States,
international partners and WHO with a road map
and menu of policy options which, when imple-
mented collectively between 2013 and 2020, will
contribute to progress on 9 global NCD targets to be
attained in 2025, including a 25% relative reduction
in premature mortality from NCDs by 2025. WHO
and other UN Organizations will support national
efforts with upstream policy advice and sophisticated
technical assistance, ranging from helping govern-
ments to set national targets to implement even rela-
tively simple steps which can make a huge difference,
such as raising tobacco taxes, reducing the amount
of salt in foods and improving access to inexpensive
drugs to prevent heart attacks and strokes.” [58]
The commitment of other UN agencies to NCD action
in their policy documents varies. United Nations Devel-
opment Programme (UNDP) appears to prioritise NCDs
in its policies more than others, namely UNICEF and
UNFPA, which appear to have recently expanded their
focus to NCDs. As the UNICEF strategy states, after “the
repeated calls for action, UNICEF has committed to in-
tegrating NCDs across programme sectors” [59]. UNDP
discusses NCDs in its health policy as an impediment to
development, and poverty reduction that deepens
health-related disadvantages, exclusion, and inequality
among different groups in the societies [60]. UNDP is
supporting nations to develop their national NCD in-
vestment cases based on its partnership with WHO [61].
“The social and economic burden of NCDs on the
poor is rapidly growing. NCDs are now the single
greatest cause of preventable illness, disability and
mortality worldwide, and low- and middle-income
countries bear a disproportionate burden. NCDs
are by far the main cause of disability. For many
people, intersecting vulnerabilities due to more
than one ascribed or intrinsic identity, including
gender, age, income, ethnicity, disability, sexual
orientation and nationality, as well as indigenous,
refugee, displaced or migratory status and religion
or caste, may exacerbate health-related disadvan-
tages, exclusion and inequality … UNDP partners
closely with WHO to strengthen whole-of-
government and whole-of-society NCD responses,
including through implementation of relevant
WHO-recommended approaches and agreements
such as the WHO Global Action Plan for the Pre-
vention and Control of Noncommunicable Dis-
eases 2013–2020” [60].
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UNICEF recognises NCDs in its policy as a barrier to
children’s rights to health [59]. It is strengthening health
systems and promoting integrated, multisectoral policies
and programmes [59]. Even though UNFPA’s strategy
does not make a clear reference to NCDs [62], UNFPA
is committed to NCD work through promoting HPV
vaccination, promoting cervical and breast cancer,
healthy life choices, and strengthening mental health ser-
vices to promote health of women and young people
[63]. The EU’s International Cooperation and Develop-
ment Policy makes no explicit reference to NCDs and
identifies its health priorities as child and maternal
health (i.e., nutrition, immunisation, reproductive health)
and HIV/AIDS. Nonetheless, SDGs are presented as a
backbone of the policy with an overall vision of the EU
being to promote growth to end poverty and help part-
ners achieve the SDGs, whilst being mindful of human
rights and the availability of natural resources [64].
In the reviewed documents, multilateral actors empha-
sised that NCD action requires funding, which is very
limited. There is competition for funding among multi-
lateral actors and other actors. Value for money has
been repeatedly mentioned as a key prerequisite for
attracting funding. Further, multilateral actors stressed
the need to increase public-private partnerships (PPP)
with NGOs and other private actors to mobilise re-
sources to tackle NCDs in the environment of economic
challenges that affect flows of aid [52, 53, 59–61]. For
example, WHO has developed a handbook for engage-
ment with non-state actors, including NGOs [65].
Philanthropic foundations
Around 10% of NCD funding in 2019 was contrib-
uted by the Gates Foundation (highest among all
actors reviewed) [66]. However, this represents only
1.84% of its health funding in 2019 [66]. No explicit
policy document was found. The available informa-
tion on the website of the Gates Foundation shows
that it has four primary priorities: a) working across
diseases to identify the public goods that accelerate
global health impact and reduce the threat of epi-
demics; b) technical innovation to design, develop
and deploy these public goods; c) vaccine develop-
ment and manufacturing; and d) building high-
quality modelling and forecasting capabilities in-
formed by trustworthy primary data [67]. In rela-
tion to NCDs, the foundation supports HPV
vaccination development and use [67]. The Gates
Foundation, together with the Bloomberg Philan-
thropies and Canadian International Development
Research Centre, have also started providing finan-
cial and technical support for tobacco prevention
and control in Africa [29].
Discussion
This paper analysed global actors’ funding and policy
priorities regarding NCDs. To date, the literature has
studied global actors’ NCD-related investment and pol-
icies separately. Concerning global actors’ NCD policies,
the literature has predominantly focused on WHO pol-
icies related to NCDs, indicating a need to broaden the
policy discussion [1, 2, 19, 22, 26, 29, 32–35, 37, 68–70].
Policies of other bilateral and multilateral actors have re-
ceived little attention. Only a few available studies have
assessed global health strategies of bilateral donors in
general [50, 71]. With regard to funding, Nugent and
colleagues have investigated NCD funding provided by
bilateral, multilateral, and other international actors in
the past decade by looking at funders, the chronology of
aid, and funding volume [7, 14]. Recently, WHO ana-
lysed global spending on health, including NCD finan-
cing internationally and nationally [72]. This paper has
taken a different approach by analysing global actors’
funding and policy priorities together.
By looking at funding and policy priorities conjointly,
the analysis has identified a lack of alignment between
policy and investment priorities of global actors. Prior-
ities stated in the policies and funding allocations are
weakly linked. Overall, there is a low prioritisation of
NCDs despite a broad recognition that they are a grow-
ing threat. The current policies prioritise diseases that
are infectious and of epidemic risk. NCDs do not seem
to be seen to present the same global health security
risks of communicable diseases and epidemics, which
may be one of the factors in their deprioritisation. NCDs
are predominantly seen by donors as a barrier to eco-
nomic development, poverty reduction, and health sys-
tem sustainability. Bilateral donors primarily focus on
preventing NCDs with emphasis on curbing tobacco and
excessive alcohol consumption and promoting nutrition
and physical exercise. While these donors recognise the
importance of multisectoral cooperation and health sys-
tem strengthening in terms of surveillance, management,
and care of NCDs, these are not fully spelled out in their
policies.
Most multilateral actors articulate more elaborate ac-
tions in their policies, which are ultimately concerned
with providing national governments with options of
policies and interventions (e.g., best-buys and case in-
vestments) to prevent and control NCDs. However, up-
take of these options by national governments has been
limited, with prevention at the individual level being pre-
ferred, while costly interventions concerning NCD care
are being overlooked [35, 73, 74]. This is mainly due to
such factors as limited funding and capacity, and the
challenge of tackling the interests of industries such as
tobacco, alcohol, sugary beverages, and unhealthy food
[23, 26, 28–30]. The applicability of the policy options
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offered by multilateral actors such as WHO best-buys to
LMICs has also been questioned. The cost-effectiveness
of best-buys from high-income countries cannot be fully
transferred to LMICs as they do not have extensive
health systems, while evidence from LMICs is lacking
[25, 74–79]. Research capacity and infrastructure across
LMICs remain inadequate, impeding the evidence gener-
ation needed for designing and implementing NCD in-
terventions and policies in LMICs [35, 74, 80]. The
distribution of investment regarding NCDs across actors
and areas of health is inadequate to address NCDs’
threats in resources poor settings in particular. NCD
support substantially comes from “non-traditional” ac-
tors, i.e., philanthropic foundations and NGOs, whose
role and priorities are less transparent and less studied.
The weak capacity of health systems in low-income
countries (LICs,) particularly in fragile states, to deal
with escalating rates of NCDs, the sequelae of that for
their populations and development trajectories, and
current patterns of DAH spending, especially the signifi-
cant dependence on philanthropic funds, pose risks to a
strategic response to NCDs.
Concerning NGOs, the analysis showed that NGO
work on NCDs is under-researched. The limited litera-
ture indicates that NGOs engaged in NCD prevention
and management are diverse, ranging from large alli-
ances and associations to national not-for-profit organi-
sations. In NCD tackling efforts, NGOs have contributed
to policy development and interactions between various
actors, technical support, capacity building, and resource
mobilisation [8, 18, 24, 26, 27, 29, 81–83]. At the na-
tional level, NGOs, especially local ones, are involved in
providing NCD services, including mental health, par-
ticularly to disadvantaged groups [22, 27, 84–87]. How-
ever, NGOs involved in NCDs and health systems
struggle with sustainability as the local government
structures still lack funding and the capacity to take over
their activities [88]. Thus, their relevance to the local
context is questioned as their approach appears to be
top-down, driven by external agendas and expertise [88].
Drawing on the outcomes of this study, several ave-
nues for future research can be stated. The first avenue
is to expand policy analysis of prioritisation (or lack of
it) within funders to understand the low allocations to
NCDs, a major burden of illness group, and how those
might be influenced. The second research direction is to
investigate how NCD support is allocated internally, i.e.,
to what extent funding matches needs within the NCD
arena and how this is influenced by funder priorities.
The third avenue is to examine and understand how the
international funder dynamics analysed by this study
play out at the national level in terms of prioritisation of
NCDs (overall and for specific components within them,
including referral for diagnostics, curative and palliative
care). Lastly, future research can explore agenda-setting
in the philanthropic foundations and NGOs related to
NCDs to understand their role and influence on NCD
prevention and control in LMICs. A political economy
lens would be appropriate to examine these three ques-
tions (Loffreda et al., forthcoming).
Limitations
While our review constituted a comprehensive and
rigorous search and screening of sources, a number of
limitations should be highlighted. Firstly, as is common
in policy document analysis, outdated policy documents
had to be included. All effort was made to find the most
up-to-date policy documents to mitigate this issue wher-
ever possible. Additionally, while published studies were
restricted to those published from 2010 onwards, studies
from the literature search suffered the same limitation.
All results were therefore viewed within their historical
context. Secondly, studies in the analysis showed an
anglophone bias due to the English language restriction
in our eligibility criteria. Results must, therefore, be
interpreted with this in mind. Thirdly, while our
searches were comprehensive, there are likely docu-
ments, which were not available to us that have been
overlooked. However, with 70 studies, 31 policy docu-
ments, and data from the Global Health Data Visualisa-
tion Tool included, the impact of any overlooked studies
on our findings is likely minimal. Fourth, since no expli-
cit category was available in the Financing Global Health
Data Tool for multilateral actors among funding sources,
we used data from two subcategories of “Other Sources”
(Other-Development Banks and Other-UN Agencies) for
analysing funding of multilateral actors covered in our
study (i.e., World Bank, Asian Development Bank, Afri-
can Development Bank, Inter-American Development
Bank, WHO, UNDP, UNICEF, UNFPA). Further, we
recognised the difficulties with disentangling NCDs from
integrated programmes. To mitigate this, we used a spe-
cific category for NCDs available in the Global Health
Data Tool. Finally, little information could be sourced
on the names of philanthropies investing in NCDs – the
Financing Global Health database did not provide the
names of these, and information was also scarce in the
published literature.
Conclusion
This paper mapped the key global actors (bilateral,
multilateral, and non-for-profit actors) investing in NCD
prevention and management. It also reviewed their pol-
icies as a response to a recent statement that slow pro-
gress towards to SDG 3.4 may be due to a lack of
commitment to bold policies. Key conclusions from the
analysis include that DAH to NCDs remains limited,
and there is a lack of alignment between stated policy
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goals and patterns of investment. There is also a low pri-
oritisation of NCDs, notwithstanding a wide recognition
of their expanding threat. The current allocation of
NCD investment across actors is inadequate to address
NCD challenges in resource-poor settings in particular.
Lastly, philanthropic foundations and NGOs provide
substantial support for NCD prevention and manage-
ment, but their roles and priorities need further
research.
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